VX-210
VX15-210-101
Phase 3 small_molecule terminated
Quick answer
VX-210 for Cervical Spinal Cord Injury is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Cervical Spinal Cord Injury
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated